Anyone interested in enrolling in purported studies if/when finally offered in EU or abroad might want to first ascertain criteria for volunteers. Eg: Are present finasteride/minoxidil. users disqualified from phase to program?
Naturally one would expect all pre/requisite(s) will be disclosed by a closer date to the purported study.
Even still I recall a not so recent study that strictly sought (Androgenetic Alopecia)volunteers who were treatment free of all (finasteride/min)respective hair loss therapies in general, for better than 6 months out from observation date. Something maybe for our prospective participant might want to prepare for well in advance, if the opportunity comes?
So with respect to the diminutive number of patients initially treated and followed (6 at 6 months) I found two things especially unique (so far) One being the claim of 100% patient response. Secondly, the fact that both genders were included is overall positive for all afflicted.
I never recommend anyone putting their cart before the horse, but we can cautiously hope STYLE/Keratem ph. 2 clinical prove as good as findings demonstrate here and will be available for "affordable" commercial release SOON.